The Goldman Sachs Group, Inc. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 4:45 pm Sale |
2023-12-29 | 13G | Atara Biotherapeutics, Inc. ATRA |
GOLDMAN SACHS GROUP INC GS |
23,225 0.600% |
-221,105 (-90.49%) |
Filing |
| 2023-02-06 5:36 pm Purchase |
2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
GOLDMAN SACHS GROUP INC GS |
244,330 6.400% |
244,330 (New Position) |
Filing |